Asia Pacific ePRO, ePatient Diaries, and eCOA Market is expected to reach US$ 964.2 million by 2028

Published Date: 04 Jun 2021

Report : Asia Pacific ePRO, ePatient Diaries, and eCOA Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type of Solution (ECOA (Electronic Clinical Outcome Assessments), EPROs (Patient Reported Outcomes), ClinROs (Clinician Reported Outcomes), ObsROs (Observer Reported Outcomes), PerfOs (Performance Outcomes), and ePatient Diaries); Modality (Computer, and Mobile Devices (Smartphones and Tablets)); End User (Clinical Trial Sponsors, Contract Research Organizations (CRO’s), Hospitals, Academic Institutes, Pharmaceutical Companies, and Others)

e-Clinical Outcome Assessments Segment has the Largest Share of Type of Solution in the Asia Pacific ePRO, ePatient Diaries, and eCOA Market during 2021–2028

According to The Insight Partners market research study on “Asia Pacific ePRO, ePatient Diaries, and eCOA Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Type of Solution, Modality, and End User,” is expected to reach US$ 964.2 million by 2028 from US$ 348.8 million in 2021. The market is estimated to grow at a CAGR of 15.6% from 2021 to 2028. The report provides trends prevailing in the Asia Pacific ePRO, ePatient Diaries, and eCOA market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the increasing demand for electronic health records (EHRs), rising use of smartphones and growing demand for clinical trials are the key factors driving the market growth. However, the market is expected experiencing slow growth during the forecast period owing to the concerns regarding data privacy.

The DIA China Digital Health Community organized a series of Remote Digital Clinical Trials During COVID-19 Pandemic online seminars to increase global interest in remote clinical trials and digital clinical trial resources. Veteran clinicians and researchers presented real-life examples of remote clinical trial and digital trial technology implementations in China and strategies and plans based on their experiences. Sponsors and CROs have been able to preserve their business continuity in China by using remote clinical trials to overcome the difficulties of conducting conventional clinical trials faced by the COVID-19 pandemic (impacting on-site subject visits, data monitoring, and drug delivery). However, since these trials are just getting underway in China, it's important to optimize the effect of these technologies and services, and relevant regulations should evolve to support these developments accordingly. Thus, ePRO, e-Patient Diaries, and eCOA market is moderately impacted due to COVID -19.

The market for ePRO, ePatient Diaries, and eCOA market is segmented into type of solution, modality, and end user. In 2020, the eCOA (Electronic Clinical Outcome Assessments) segment accounted for the Asia Pacific ePRO, ePatient diaries, and eCOA market's largest market share. This large share can be attributed to the advantages offered by eCOA, as eCOA uses technology such as smartphones, laptops, computers to enable patients, nurses, and doctors to consult directly about medical test results. ECOA provides highly accurate knowledge that better understands and simplifies the acceptance process for patient reviews in clinical trials. In addition, the increasing cost for pharmaceutical manufacturers of modern overall drug development methodologies has led to their use of electronic information collection by way of paper-based processes. Data processing across eCOA networks improves the quality of the information gathered, harmonizes data systems, and gives users valuable benefits, such as data interpretation.

ERT Clinical, ArisGlobal LLC, The Diary Pte. Ltd, ICON PLC, PAREXEL INTERNATIONAL CORPORATION, Anju Software, Inc., Kayentis, Bracket Global LLC, Dassault Systèmes SE, and CRF Health are among the leading companies in the Asia Pacific ePRO, ePatient Diaries, and eCOA market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in February 2021, ERT, announced a powerful new solution for enabling the collection, processing and analysis of photos and audio as part of clinical trial eCOA assessments. This solution promises to streamline and drive patient compliance with data collection, while safeguarding patient privacy, confidentiality, and data security.

The report segments the Asia Pacific EPRO, ePatient Diaries, and eCOA market as follows:

By Type of Solution

  • eClinical Outcome Assessments
  • e-Patient Reported Outcomes
  • Clinician Reported Outcomes
  • Observer Reported Outcomes
  • Performance Outcomes
  • e-Patient Diaries

By Modality

  • Computer
  • Mobile Devices

By End User

  • Clinical Trial Sponsors
  • Contract Research Organizations
  • Hospitals
  • Academic Institutes
  • Pharmaceutical Companies
  • Others

By Country

  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
Contact Us
Contact Person: Sameer Joshi 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com     

 

Download Free PDF Brochure